TBI-1501

· Takara Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TBI-1501, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 1, Phase 2]